Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstalliTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
In February 2020, researchers reported a 3.5-angstrom cryo-electron microscopy map of the SARS-CoV-2 spike protein in its prefusion shape. The structure gave vaccine and antibody researchers a detailed view of a key viral target—but it was a tool for further work, not evidence that a vaccine had already been shown to work.
What the researchers mapped
In a study published online in Science on February 19, 2020, Daniel Wrapp and colleagues determined the structure of the SARS-CoV-2 spike as a three-part protein complex, or trimer. They used cryo-electron microscopy (cryo-EM), a technique that reconstructs a molecule’s shape from many images, and reported a resolution of 3.5 angstroms. The Science paper describes the technical findings; the RCSB Protein Data Bank entry 6VSB records the structure.
The team captured the spike in its prefusion conformation: the shape it has before it changes to help the virus enter a cell. In the predominant state described in the study, one of the three receptor-binding domains (RBDs) was rotated upward. That “up” position exposes a receptor-accessible surface.
Recommended Free Tools
Why the spike was an important target
The spike helps SARS-CoV-2 bind to host cells through the ACE2 receptor. Blocking or otherwise studying this interaction offered a way to investigate how infection begins. Wrapp and colleagues wrote in their study abstract, “The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics.”
#1 Best Overall
A detailed structural map can help researchers see where antibodies might bind and make informed choices about which parts of a protein to use or modify when designing an antigen. It can also support studies of how the virus engages ACE2. The contemporary Chemistry World report, published February 20, 2020, quoted research leader Jason S. McLellan describing the spike as a target for vaccines, antibodies, and small molecules intended to prevent viral entry.
What the reported measurements did—and did not—show
Wrapp and colleagues reported approximately 10- to 20-fold higher ACE2 affinity for the SARS-CoV-2 spike than for the SARS-CoV spike in their comparison. This was a biophysical measurement, not a measure of how quickly the virus spreads, how severe an illness becomes, or how well a vaccine protects people.
Rank #2
The team also found that several tested monoclonal antibodies directed at the SARS-CoV RBD did not appreciably bind the SARS-CoV-2 spike. This points to limited cross-reactivity among those tested antibodies; it does not establish that all antibodies against SARS-CoV fail to recognize SARS-CoV-2.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →Why a structure was a starting point, not a vaccine result
The map helped establish a molecular reference for vaccine and antibody research at an early point in the pandemic. But a structure alone cannot show that a vaccine candidate is safe, triggers a useful immune response in people, or prevents disease. Those questions require separate laboratory and clinical testing.
The phrase “offers hope for vaccine development” reflected the forward-looking significance of the result when it was reported in 2020. The study showed researchers what the spike looked like in a key state; it did not prove that the map by itself produced an effective vaccine.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
